ABL Bio Inc.
ABL Bio Inc.
Share · KR7298380007 (XKOS)
Overview
No Price
Closing Price XKOS 28.10.2025: 95.500,00 KRW
28.10.2025 06:30
Current Prices from ABL Bio Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XKOS: KOSDAQ
KOSDAQ
298380.KQ
KRW
28.10.2025 06:30
95.500,00 KRW
1.100,00 KRW
+1,17 %
Share Float & Liquidity
Free Float 74,05 %
Shares Float 35,75 M
Shares Outstanding 48,29 M
Invested Funds

The following funds have invested in ABL Bio Inc.:

Fund
iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF USD (Dist)
Vol. in million
73,57
Percentage (%)
0,07 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
155,08
Percentage (%)
0,0098 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
30,63
Percentage (%)
0,0098 %
Company Profile for ABL Bio Inc. Share
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. The company is headquartered in Seongnam, South Korea.
Get up to date insights from finAgent about ABL Bio Inc.

Company Data

Name ABL Bio Inc.
Company ABL Bio Inc.
Website http://www.ablbio.com
Primary Exchange XKOS KOSDAQ
ISIN KR7298380007
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Sang Hoon Lee
Market Capitalization 4.213 Mrd.
Country South Korea
Currency KRW
Employees 0,1 T
Address 16 Daewangpangyo-Ro 712 Beon-Gil, 13488 Seongnam
IPO Date 2018-12-19

Ticker Symbols

Name Symbol
KOSDAQ 298380.KQ
More Shares
Investors who hold ABL Bio Inc. also have the following shares in their portfolio:
AM-SP GL.IN.ESG EOA
AM-SP GL.IN.ESG EOA ETF
UBS (LUX) BOND SICAV - CONVERT GLOBAL (EUR) I-A2-ACC
UBS (LUX) BOND SICAV - CONVERT GLOBAL (EUR) I-A2-ACC ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025